Holick MF: The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanisms of action.
Mol Aspects Med 2008, 29:361–368.
Cantorna MT, Zhu Y, Froicu M, Wittke A: Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system.
Am J Clin Nutr 2004, 80:1717S-1720S.
Holick MF: Vitamin D deficiency.
N Engl J Med 2007, 357:266–281.
Jones AP, Tulic MK, Rueter K, Prescott SL: Vitamin D and allergic disease: sunlight at the end of the tunnel?
Nutrients 2012, 4:13–28.
Zhang HL, Wu J: Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis.
Neurosci Bull 2010, 26:445–454.
Hamza RT, Awwad KS, Ali MK, Hamed AI: Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity.
Med Sci Monit 2011, 17:CR711-CR718.
Sternberg Z: Autonomic dysfunction: A unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D(3), and Epstein-Barr virus.
Autoimmun Rev 2012,:. [Epub ahead of print]
Singh VK, Warren RP, Averett R, Ghaziuddin M: Circulating autoantibodies to neuronal and glial filament proteins in autism.
Pediatr Neurol 1997, 17:88–90.
Singh VK, Lin SX, Yang VC: Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism.
Clin Immunol Immunopathol 1998, 89:105–108.
Mostafa GA, El-Sayed ZA, Abd El Aziz MM, El-Sayed MF: Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children.
J Child Neurol 2008, 23:1413–1418.
Mostafa GA, Al-Ayadhi LY: Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity.
J Neuroinflammation 2011, 8:39.
Mostafa GA, Al-Ayadhi LY: A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein. auto-antibodies in autistic children.
J Neuroinflammation 2011, 8:71.
Mostafa GA, Al-Ayadhi LY: The relationship between the increased frequency of serum antineuronal antibodies and the severity of autism in children.
Eur J Paediatr Neurol 2012,:. [Epub ahead of print]
Mostafa GA, Al-Ayadhi LY: The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism.
J Neuroinflammation 2011, 8:180.
Al-Ayadhi LY, Mostafa GA: A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children.
J Neuroinflammation 2012, 9:54.
Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN: Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism.
J Child Neurol 1999, 14:388–394.
Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ: Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders.
Pediatrics 2003, 112:420–424.
Croen LA, Grether JK, Yoshida CK, Odouli R, Van de Water J: Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case–control study.
Arch Pediatr Adolesc Med 2005, 159:151–157.
Mostafa GA, Kitchener N: Serum anti-nuclear antibodies as a marker of autoimmunity in Egyptian autistic children.
Pediatr Neurol 2009, 40:107–112.
Mostafa GA, Shehab A: The link of C4B null allele to autism and to a family history of autoimmunity in Egyptian autistic children.
J Neuroimmunol 2010, 223:115–119.
Mostafa GA, Shehab AA, Fouad NR: Increased frequency of CD4+CD25high regulatoryT cells in the peripheral blood of Egyptian children with autism.
J Child Neurol 2010, 25:328–335.
Mostafa GA, El-Hadidi ES, Hewedi DH, Abdou MM: Oxidative stress in Egyptian children with autism: relation to autoimmunity.
J Neuroimmunol 2010, 219:114–118.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th edition. American Psychiatric Association, Washington, DC; 1994.
Schopler E: Reichler RJ, Renner BR: The Childhood Autism Rating Scale (CARS), for Diagnostic Screening and Classification in Autism. Irvington, New York, NY; 1986.
Canadian Paediatric Society: Vitamin D supplementation recommendations for Canadian mothers and infants.
Paediatr Child Health 2007, 12:583–598.
Cohly HH, Panja A: Immunological findings in autism.
Int Rev Neurobiol 2005, 71:317–341.
Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K, Vojdani E: Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A.
J Neuroimmunol 2002, 129:168–177.
Al-Ayadhi LY, Mostafa GA: Low plasma progranulin levels in children with autism.
J Neuroinflammation 2011, 8:111.
Al-Ayadhi LY, Mostafa GA: Increased serum osteopontin levels in autistic children: Relation to the disease severity.
Brain Behav Immun 2011, 25:1393–1398.
Eyles DW, Burne TH, McGrath JJ: Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease.
Front Neuroendocrinol 2012,:. [Epub ahead of print]
Kočovská E, Fernell E, Billstedt E, Minnis H, Gillberg C: Vitamin D and autism: clinical review.
Res Dev Disabil 2012, 33:1541–1550.
Meguid NA, Hashish AF, Anwar M, Sidhom G: Reduced serum levels of 25-hydroxy and 1,25-dihydroxy vitamin D in Egyptian children with autism.
J Altern Complement Med 2010, 16:641–645.
Yan J, Feng J, Craddock N, Jones IR, Cook EH, Goldman D, Heston LL, Chen J, Burkhart P, Li W, Shibayama A, Sommer SS: Vitamin D receptor variants in 192 patients with schizophrenia and other psychiatric diseases.
Neurosci Lett 2005, 380:37–41.
Humble MB: Vitamin D, light and mental health.
J Photochem Photobiol B 2010, 101:142–149.
Kinney DK, Barch DH, Chayka B, Napoleon S, Munir KM: Environmental risk factors for autism: do they help cause de novo genetic mutations that contribute to the disorder?
Med Hypotheses 2010, 74:102–106.
Cannell JJ: Autism and vitamin D.
Med Hypotheses 2008, 70:750–759.
Grant WB, Soles CM: Epidemiologic evidence supporting the role of maternal vitamin D deficiency as a risk factor for the development of infantile autism.
Dermatoendocrinol 2009, 1:223–228.
Evatt ML, DeLong MR, Grant WB, Cannell JJ, Tangpricha V: Autism spectrum disorders following in utero exposure to antiepileptic drugs.
Neurology 2009, 73:997.
Levenson CW, Figueirôa SM: Gestational vitamin D deficiency. long-term effects on the brain.
Nutr Rev 2008, 66:726–729.
Holmes VA, Barnes MS, Alexander HD, McFaul P, Wallace JM: Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study.
Br J Nutr 2009, 31:1–6.
Cai D, Qiu J, Cao Z, McAtee M, Bregman BS, Filbin MT: Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate.
J Neurosci 2001, 21:4731–4739.
Steck AJ, Stalder AK, Renaud S: Anti-myelin-associated glycoprotein neuropathy.
Curr Opin Neurol 2006, 19:458–463.
Chambers ES, Hawrylowicz CM: The impact of vitamin D on regulatory T cells.
Curr Allergy Asthma Rep 2011, 11:29–36.
Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A: 1α,25-Dihydroxyvitamin d3 has a direct effect on naive CD4[+] T cells to enhance the development of Th2 cells.
J Immunol 2001, 167:4974–4980.
Vignali DA, Collison LW, Workman CJ: How regulatory T cells work.
Nat Rev Immunol 2008, 8:523–532.
Bettelli E, Korn T, Oukka M, Kuchroo VK: Induction and effector functions of T(H)17 cells.
Nature 2008, 453:1051–1057.
Cannell JJ: On the aetiology of autism.
Acta Paediatr 2010, 99:1128–1130.
Antico A, Tampoia M, Tozzoli R, Bizzaro N: Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature.
Autoimmun Rev 2012,:. [Epub ahead of print]
Cannell JJ, Hollis BW: Use of vitamin D in clinical practice.
Altern Med Rev 2008, 13:6–20.